Osteoporosis and Ageing Affects the Migration of Stem Cells and This is Ameliorated by Transfection with CXCR4

Overview

Journal Bone Joint Res

Date 2017 Jun 4

PMID 28576885

Citations 21

Authors

A Sanghani-Kerai

M Coathup

S Samazideh

P Kalia

L Di Silvio

B Idowu

G Blunn

Affiliations

Soon will be listed here.

Abstract

Objectives: Cellular movement and relocalisation are important for many physiologic properties. Local mesenchymal stem cells (MSCs) from injured tissues and circulating MSCs aid in fracture healing. Cytokines and chemokines such as Stromal cell-derived factor 1(SDF-1) and its receptor chemokine receptor type 4 (CXCR4) play important roles in maintaining mobilisation, trafficking and homing of stem cells from bone marrow to the site of injury. We investigated the differences in migration of MSCs from the femurs of young, adult and ovariectomised (OVX) rats and the effect of CXCR4 over-expression on their migration.

Methods: MSCs from young, adult and OVX rats were put in a Boyden chamber to establish their migration towards SDF-1. This was compared with MSCs transfected with CXCR4, as well as MSCs differentiated to osteoblasts.

Results: MSCs from OVX rats migrate significantly (p < 0.05) less towards SDF-1 (9%, sd 5%) compared with MSCs from adult (15%, sd 3%) and young rats (25%, sd 4%). Cells transfected with CXCR4 migrated significantly more towards SDF-1 compared with non-transfected cells, irrespective of whether these cells were from OVX (26.5%, sd 4%), young (47%, sd 17%) or adult (21%, sd 4%) rats. Transfected MSCs differentiated to osteoblasts express CXCR4 but do not migrate towards SDF-1.

Conclusions: MSC migration is impaired by age and osteoporosis in rats, and this may be associated with a significant reduction in bone formation in osteoporotic patients. The migration of stem cells can be ameliorated by upregulating CXCR4 levels which could possibly enhance fracture healing in osteoporotic patients. A. Sanghani-Kerai, M. Coathup, S. Samazideh, P. Kalia, L. Di Silvio, B. Idowu, G. Blunn. Osteoporosis and ageing affects the migration of stem cells and this is ameliorated by transfection with CXCR4. 2017;6:-365. DOI: 10.1302/2046-3758.66.BJR-2016-0259.R1.

Citing Articles

Nanoparticles and Mesenchymal Stem Cell (MSC) Therapy for Cancer Treatment: Focus on Nanocarriers and a si-RNA CXCR4 Chemokine Blocker as Strategies for Tumor Eradication In Vitro and In Vivo.

Merino J, Cabana-Munoz M Micromachines (Basel). 2023; 14(11).

PMID: 38004925 PMC: 10673568. DOI: 10.3390/mi14112068.

Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1.

Xia S, Ma Z, Wang B, Gao F, Guo S, Chen X J Orthop Surg Res. 2023; 18(1):500.

PMID: 37454090 PMC: 10349431. DOI: 10.1186/s13018-023-03998-w.

Surface engineering of titania nanotubes incorporated with double-layered extracellular vesicles to modulate inflammation and osteogenesis.

Zhao Q, Zhang Y, Xiao L, Lu H, Ma Y, Liu Q Regen Biomater. 2021; 8(3):rbab010.

PMID: 34211726 PMC: 8240597. DOI: 10.1093/rb/rbab010.

The Bone Regeneration Capacity of BMP-2 + MMP-10 Loaded Scaffolds Depends on the Tissue Status.

Garcia-Garcia P, Reyes R, Rodriguez J, Martin T, Evora C, Diaz-Rodriguez P Pharmaceutics. 2021; 13(7).

PMID: 34209593 PMC: 8308972. DOI: 10.3390/pharmaceutics13070979.

Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy.

Harman R, Marx C, Van de Walle G Front Cell Dev Biol. 2021; 9:654885.

PMID: 33869217 PMC: 8044970. DOI: 10.3389/fcell.2021.654885.

References

Haasters F, Docheva D, Gassner C, Popov C, Bocker W, Mutschler W . Mesenchymal stem cells from osteoporotic patients reveal reduced migration and invasion upon stimulation with BMP-2 or BMP-7. Biochem Biophys Res Commun. 2014; 452(1):118-23. DOI: 10.1016/j.bbrc.2014.08.055. View

Batouli S, Miura M, Brahim J, Tsutsui T, Fisher L, Gronthos S . Comparison of stem-cell-mediated osteogenesis and dentinogenesis. J Dent Res. 2003; 82(12):976-81. DOI: 10.1177/154405910308201208. View

Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S . Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood. 2005; 105(10):3793-801. DOI: 10.1182/blood-2004-11-4349. View

Shao H, Xu Q, Wu Q, Ma Q, Salgueiro L, Wang J . Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration. J Cell Mol Med. 2010; 15(10):2046-56. PMC: 3076550. DOI: 10.1111/j.1582-4934.2010.01231.x. View

Dar A, Kollet O, Lapidot T . Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol. 2006; 34(8):967-75. DOI: 10.1016/j.exphem.2006.04.002. View

Isaacs J, Shidiak L, Harris I, Szomor Z . Femoral insufficiency fractures associated with prolonged bisphosphonate therapy. Clin Orthop Relat Res. 2010; 468(12):3384-92. PMC: 2974861. DOI: 10.1007/s11999-010-1535-x. View

Imitola J, Raddassi K, Park K, Mueller F, Nieto M, Teng Y . Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A. 2004; 101(52):18117-22. PMC: 536055. DOI: 10.1073/pnas.0408258102. View

Ugarte F, Ryser M, Thieme S, Fierro F, Navratiel K, Bornhauser M . Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells. Exp Hematol. 2009; 37(7):867-875.e1. DOI: 10.1016/j.exphem.2009.03.007. View

Kular J, Tickner J, Chim S, Xu J . An overview of the regulation of bone remodelling at the cellular level. Clin Biochem. 2012; 45(12):863-73. DOI: 10.1016/j.clinbiochem.2012.03.021. View

10.

Liu Z, Zhuge Y, Velazquez O . Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009; 106(6):984-91. DOI: 10.1002/jcb.22091. View

11.

Abbott J, Huang Y, Liu D, Hickey R, Krause D, Giordano F . Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004; 110(21):3300-5. DOI: 10.1161/01.CIR.0000147780.30124.CF. View

12.

Stich S, Haag M, Haupl T, Sezer O, Notter M, Kaps C . Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12. Cell Tissue Res. 2009; 336(2):225-36. DOI: 10.1007/s00441-009-0768-z. View

13.

Karsdal M, Larsen L, Engsig M, Lou H, Ferreras M, Lochter A . Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem. 2002; 277(46):44061-7. DOI: 10.1074/jbc.M207205200. View

14.

Raisz L . Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005; 115(12):3318-25. PMC: 1297264. DOI: 10.1172/JCI27071. View

15.

Ito H . Chemokines in mesenchymal stem cell therapy for bone repair: a novel concept of recruiting mesenchymal stem cells and the possible cell sources. Mod Rheumatol. 2010; 21(2):113-21. DOI: 10.1007/s10165-010-0357-8. View

16.

Bhukhai K, Suksen K, Bhummaphan N, Janjorn K, Thongon N, Tantikanlayaporn D . A phytoestrogen diarylheptanoid mediates estrogen receptor/Akt/glycogen synthase kinase 3β protein-dependent activation of the Wnt/β-catenin signaling pathway. J Biol Chem. 2012; 287(43):36168-78. PMC: 3476284. DOI: 10.1074/jbc.M112.344747. View

17.

Hong L, Colpan A, Peptan I . Modulations of 17-beta estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells. Tissue Eng. 2007; 12(10):2747-53. DOI: 10.1089/ten.2006.12.2747. View

18.

Antebi B, Pelled G, Gazit D . Stem cell therapy for osteoporosis. Curr Osteoporos Rep. 2014; 12(1):41-7. DOI: 10.1007/s11914-013-0184-x. View

19.

Mannello F, Tonti G, Bagnara G, Papa S . Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells. Stem Cells. 2005; 24(3):475-81. DOI: 10.1634/stemcells.2005-0333. View

20.

Lien C, Chih-Yuan Ho K, Lee O, Blunn G, Su Y . Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res. 2008; 24(5):837-48. DOI: 10.1359/jbmr.081257. View